La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.
Show more...
CEO
Employees
59
Country
US
ISIN
US5034596040
WKN
000A1XB6B
Listings
0 Comments
Share your thoughts
FAQ
What is La Jolla Pharmaceutical stock price today?▼
The current price of LJPC is $6.22 USD — it has increased by +0% in the past 24 hours. Watch La Jolla Pharmaceutical stock price performance more closely on the chart.
What is La Jolla Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange La Jolla Pharmaceutical stocks are traded under the ticker LJPC.
What is La Jolla Pharmaceutical market cap?▼
Today La Jolla Pharmaceutical has the market capitalization of 170.98M
How many employees does La Jolla Pharmaceutical have?▼
As of April 01, 2026, the company has 59 employees.
In which sector is La Jolla Pharmaceutical located?▼
La Jolla Pharmaceutical operates in the Manufacturing sector.
When did La Jolla Pharmaceutical complete a stock split?▼
The last stock split for La Jolla Pharmaceutical was on January 14, 2014 with a ratio of 1:50.
Where is La Jolla Pharmaceutical headquartered?▼
La Jolla Pharmaceutical is headquartered in San Diego, US.